Your browser doesn't support javascript.
loading
Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI.
Aminzadeh, Majid; Malekpour, Nasrin; Ghandil, Pegah.
Affiliation
  • Aminzadeh M; Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Department of Pediatrics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Malekpour N; Department of Genetics, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Ghandil P; Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: pghandil@yahoo.com.
Gene ; 706: 1-5, 2019 Jul 20.
Article in En | MEDLINE | ID: mdl-31009684
ABSTRACT

BACKGROUND:

Mucopolysaccharidosis (MPS) type VI, also known as Maroteaux-Lamy syndrome, is an autosomal recessive lysosomal storage disorder caused by a deficiency in arylsulfatase B (ARSB) enzyme. Our objectives were to investigate clinical phenotypes and performed molecular studies in Iranian patients with MPS VI, for the first time, in the southwestern Iran.

METHODS:

We studied 14 cases from 10 unrelated kindreds with MPS VI that were enrolled during 8 years. The mutational analysis of coding and flanking regions of ARSB gene was performed for the patients and their families using genomic DNA from whole blood by direct sequencing.

RESULTS:

All cases had parental consanguinity. Except one who had Fars ethnicity and presented with a very mild degree of coarse face, but normal otherwise, even near normal height, all were from Arab ethnicity with characteristic phenotypes including severe facial changes, cardiac involvement and dysostosis multiplex. Sequencing analysis of ARSB gene revealed four pathogenic homozygote mutations, including a novel nonsense mutation c.281C>A (p.Ser94X) in 9 patients, as well as, a known nonsense mutation c.753C>G (p.Try251X) in 3 cases, and two missense mutations c.904G>A (p.Gly302Arg) and c.454C>T (p.Arg152Trp) in two cases. The type of mutations affected the severity patient's phenotypes.

CONCLUSIONS:

These findings increased the genetic databases of Iranian patients with MPS VI and would be so much helpful for the high-risk families to speed the detection of carriers with accuracy and perform the prenatal test of disorder with cost-effective in this population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mucopolysaccharidosis VI / N-Acetylgalactosamine-4-Sulfatase Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Gene Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mucopolysaccharidosis VI / N-Acetylgalactosamine-4-Sulfatase Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Gene Year: 2019 Document type: Article Affiliation country:
...